About CERTs

Annual Report Year 6

AHRQ Letter | Steering Committee Letter | Introduction | CERTs Progress | Certs Program Resources | Certs Parnerships and Collaborations | Conclusion | The CERTs Organization | Principles of CERTs Public-Private Partnerships | Peer-Reviewed Publications

Peer-Reviewed Publications

Additional Publications

• Aspinall SL, Berlin JA, Zhang Y, Metlay JP. Facility-level variation in antibiotic prescriptions for veterans with upper respiratory infections. Clin Ther 2005;27:258-262.
• Barton TD, Fishman NO, Weiner MG, LaRosa LA, Lautenbach E. High rate of coadministration of di- or tri-valent cation-containing compounds with oral fluoroquinolones: risk factors and potential implications. Infect Control Hosp Epidemiol 2005;26:93-99.
• Chan KA, for the HMO Research Network CERTs Patient Safety Study Investigators. Development of a multipurpose dataset to evaluate potential medication errors in ambulatory settings. In: Henriksen K, Battles JB, Marks ES, Lewin DI, eds. Advances in Patient Safety: From Research to Implementation. Vol 2, Concepts and Methodology. AHRQ Publication No. 05-0021-2. Rockville, MD: Agency for Healthcare Research and Quality 2005:225-238.
• Colon-Emeric CS, Casebeer L, Saag K, Allison J, Levine D, Suh TT, Lyles KW. Barriers to providing osteoporosis care in skilled nursing facilities: perceptions of medical directors and directors of nursing. J Am Med Dir Assoc 2004;5:361-366.
• Feldstein AC, Smith DH, Robertson NR, Kovach CA, Soumerai SB, Simon SR, Sittig DF, Laferriere DS, Kalter M. Design and implementation of decision support for outpatient prescribing in an electronic medical record: The Safety in Prescribing study. In: Henriksen K, Battles JB, Marks ES, Lewin DI, eds. Advances in Patient Safety: From Research to Implementation. Vol 2, Concepts and Methodology. AHRQ Publication No. 05-0021- 2. Rockville, MD: Agency for Healthcare Research and Quality 2005:35-50.
• Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G, Shoor S, Ray WA. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective nonsteroidal anti-inflammatory drugs: nested case control study. Lancet 2005;365:475-481.
• Halpern SD, Asch DA, Shaked A, Stock PG, Blumberg E. Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIV. Am J Transplant 2005;5:1319-1325.
• Halpern SD, Barton TD, Gross R, Hennessy S, Berlin JA, Strom BL. Epidemiologic studies of adverse effects of anti-retroviral drugs: how well is statistical power reported. Pharmacoepidemiol Drug Saf 2005;14:155-161.
• Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum betalactamase- producing enterobacteriaceae: variability by site of infection. Arch Intern Med 2005;165:1375-1380.
• Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, Mao X, Lautenbach E. Risk factors for increasing multidrug resistance among extended-spectrum betalactamase- producing Escherichia coli and Klebsiella species. Clin Infect Dis 2005;40:1317-1324.
• Kersun LS, Propert KJ, Lautenbach E, Bunin N, Demichele A. Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis. Pediatr Blood Cancer 2005;45:162-169.
• Kramer JM. Managing the risks of therapeutic products: proceedings of a workshop. Pharmacoepidemiol Drug Saf 2005;14:619-628.
• Lautenbach E, Harris AD, Perencevich EN, Nachamkin I, Tolomeo P, Metlay JP. Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone- resistant Escherichia coli in the gastrointestinal tract. Antimicrob Agents Chemother 2005;49:798-800.
• McPhillips H, Stille C, Smith DH, Pearson J, Stull J, Hecht J, Andrade S, Miller M, Davis R. Methodological challenges in describing medication dosing errors in children. In: Henriksen K, Battles JB, Marks ES, Lewin DI, eds. Advances in Patient Safety: From Research to Implementation. Vol 2, Concepts and Methodology. AHRQ Publication No. 05-0021-2. Rockville, MD: Agency for Healthcare Research and Quality 2005:213-223.
• Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology (Oxford) 2005;44:1038-1042.
• Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR, Jr., Saag KG. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005;64:267-272.
• Mouton JW, Vinks AA. Pharmacokinetic/ pharmacodynamic modelling of antibacterials in vitro and in vivo using bacterial growth and kill kinetics: the minimum inhibitory concentration versus stationary concentration. Clin Pharmacokinet 2005;44:201-210.
• Pearson EC, Woosley RL. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf 2005;14:747-753.
• Raebel MA, Ellis JL, Andrade SE. Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data. Pharmacoepidemiol Drug Saf 2005;14:829-836.
• Rundall TG, Fung V, Simon S, Elston-Lafata J, Simpkins J, Gunter MJ, Paez K, Robinson S, Soumerai SB, Selby JV, Uratsu C, Hsu JT. Prescribing safety in ambulatory care: physician perspectives. In: Henriksen K, Battles JB, Marks ES, Lewin DI, eds.
• Advances in Patient Safety: From Research to Implementation. Vol 2, Concepts and Methodology. AHRQ Publication No. 05-0021- 2. Rockville, MD: Agency for Healthcare Research and Quality 2005:161-171.
• Simon SR, Chan KA, Soumerai SB, Wagner AK, Andrade SE, Feldstein AC, Lafata JE, Davis RL, Gurwitz JH. Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc 2005;53:227-232.
• Simon SR, Majumdar SR, Prosser LA, Salem-Schatz S, Warner C, Kleinman K, Miroshnik I, Soumerai SB. Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial. Am J Med 2005;118:521- 528.
• Touw DJ, Neef C, Thomson AH, Vinks AA. Cost-effectiveness of therapeutic drug monitoring: a systematic review. Ther Drug Monit 2005;27:10-17.
• Viray M, Linkin D, Maslow JN, Stieritz DD, Carson LS, Bilker WB, Lautenbach E. Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance. Infect Control Hosp Epidemiol 2005;26:56-62.
• Zaoutis TE, Goyal M, Chu JH, Coffin SE, Bell LM, Nachamkin I, McGowan KL, Bilker WB, Lautenbach E. Risk factors for and outcomes of bloodstream infection caused by extendedspectrum beta-lactamaseproducing Escherichia coli and Klebsiella species in children. Pediatrics 2005;115:942-949.

To Top